Cream treatment for rough sun-damaged spots in transplant patients
Part of Cancer, Skin clinical trials.
This trial tests a cream that combines two medicines (5-FU and calcipotriene) to treat sun-damaged skin spots (actinic keratoses) on the face, scalp, or arms. It is specifically for people who have had an organ transplant and may be at higher risk for skin damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have 4 to 15 rough or scaly spots (actinic keratoses) in one area (face, scalp, or arms)
- You have had a solid organ transplant (kidney, lung, heart, liver, or pancreas)
- You have been on anti-rejection medicines for at least one year
- No active skin cancer or recent field treatment in the same area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding calcipotriol to a standard chemotherapy cream (5-fluorouracil) works better than the standard cream alone for treating actinic keratosis (precancerous sun-damaged skin spots). You may qualify if you have at least four spots on your face, scalp, neck, chest, or arms.
This trial compares a light-activated cream (photodynamic therapy) to a combination cream for treating sun-damaged skin patches called actinic keratoses. It aims to see which treatment works better with fewer side effects.
This study compares two ways to treat sun-damaged spots called actinic keratoses: freezing them (cryotherapy) or applying a chemotherapy cream (5-fluorouracil). The goal is to see which works better and is safer for people with many spots on their head, neck, arms, or legs.
This trial tests whether a combination of the chemotherapy cream 5-fluorouracil and an aluminum solution works well to treat actinic keratoses (precancerous sun-damaged spots) on the scalp or forearms. It may help if you have 4–15 of these spots and are generally healthy.
This trial tests a two-step treatment for actinic keratosis (rough, scaly patches from sun damage) on the scalp and forehead. First, the patches are frozen (cryotherapy), then a medicated ointment (tirbanibulin) is applied. The goal is to see if this combination is safe and works better than freezing alone.
This study compares two treatments for actinic keratoses (rough, sun-damaged skin spots) on the upper arms: photodynamic therapy (a light-based treatment) versus chemical peels. The goal is to see which works better, which could help you clear these precancerous spots and reduce your risk of skin cancer.
Hear when a new Actinic Keratoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.